Keck School of Medicine of USC to focus on Hispanic patients with NAFLD in multi-omics study

The Keck School of Medicine of USC has received funding from the National Institutes of Health as part of a five-year, $50.3 million “multi-omics” study of human health and disease involving six sites.

BridgeBio spins out oncology company as it focuses on heart drug

BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal

May 2, 2024

Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo

CARsgen will test its Claudin18.2 CAR T-cell candidate, dubbed CT041, in combination with Moderna’s investigational mRNA cancer vaccine in a collaboration between the two companies.

August 22, 2023

Ethnic disparities in COVID-19 mortality rates among hospitalized patients in California

The association between race and outcomes in Coronavirus Disease-2019 (COVID-19) hospitalizations in California.

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.